The application for authorisation to create or transfer an in-house pharmacy, as provided for in article L. 5126-4, is submitted by the natural person holding the authorisation to operate the establishment or by the legal representative of the legal entity concerned.
It is accompanied by a file containing the following information:
1° The number of patients to be cared for daily by the pharmacy, broken down by activity or discipline and specifying their respective locations;
2° The tasks and activities planned on its own behalf or on behalf of other pharmacies for internal use, specifically mentioned;
3° Each task or activity entrusted to another specifically named pharmacy for internal use;
4° The number of pharmacists planned to carry out the pharmacy’s tasks, and their attendance time expressed in weekly half-days;
5° The location or locations of the pharmacy’s premises;
6° The different locations of the establishments, services or organisations served by the pharmacy and, where applicable, the geographical area of operation of the home hospitalization establishments or home dialysis units served by the pharmacy;
7° A detailed, dimensioned plan of the premises;
8° The number of staff, other than pharmacists, and a description of the equipment and information system needed to carry out the tasks and activities mentioned in 2° of this article;
9° The arrangements planned for dispensing or withdrawing the medicinal products and products or objects mentioned in articles L. 4211-1 and L. 5137-1 as well as sterile medical devices on the site or sites provided for in 6° as well as in the homes of patients cared for by a holder of a home hospitalisation authorisation or a home dialysis unit;
10° The agreement or draft agreement where the internal-use pharmacy carries out a task or activity on behalf of another internal-use pharmacy or entrusts a task or activity to another internal-use pharmacy;
11° For health cooperation groups, the constituent agreement referred to in II of Article L. 5126-2 and the internal rules;
12° For establishments that are part of a regional hospital grouping, the pharmacy project of the shared medical project mentioned in I of Article L. 5126-2;
13° Where applicable, the agreement or draft agreement mentioned in I of Article L. 5126-10.